Price · last 3 months · daily close
EG price
Loading the price chart...
Daily closing prices via yfinance. Quotes are delayed. Past prices are not a guarantee of future results.
ValeriusBeta - Not investment advice
Research · S&P 500 · Financials
EG · Everest Group
The numbers, the scorecard and what analysts say, with the source for each. Information, not advice.
Value Scorecard · run 2026-10-18
13 value checks: 12 scored 1 to 5 where the data allows, plus moat evidence
42/55
moderate value score11 of 12 checks scored11 of the 12 checks that carry a score were scored from the data available. 1 could not be scored (ROIC) and was left out, so the score is out of 55 instead of 60. The label uses the same share of the available points as for a full scorecard. The moat is shown as evidence from the filings, without a score.
Earnings & returns
EPS Trend
4/5Diluted EPS: $15.19 (2022), $60.19 (2023), $31.78 (2024), $37.80 (2025). It rose every year but one and ended above 2022; the framework scores that as 4.
ROE Trend
2/5ROE (net income / common equity): 7.0% (2022), 18.8% (2023), 9.8% (2024), 10.2% (2025). Median 10.0%, lowest 7.0%; the framework scores a median 5-10% as 2.
ROIC
Not scoredROIC not available: the 10-K financial data filed with the SEC has no standard operating income figure (or pre-tax income and interest expense), total assets and current liabilities for the same fiscal year.
Profit Margins
4/5Net margin of 11.4%; the framework scores 10-20% as 4; gross margin 15.3%, operating margin 19.1%.
Balance sheet & cash
Debt-to-Equity
5/5Net cash: total debt $3.59B, total cash $3.62B. The framework scores a net cash position as 5.
Free Cash Flow
2/5Free cash flow (operating cash flow minus capital expenditure): $3.69B (2022), $4.55B (2023), $4.96B (2024), $3.07B (2025). It ended at or below 2022; the framework scores that as 2.
Retained Earnings
5/5Retained earnings, as filed in the 10-Ks (SEC EDGAR): $12.04B (2022), $14.27B (2023), $15.31B (2024), $16.57B (2025). It rose every year; the framework scores that as 5.
Valuation models
Graham IV
3/5IV = EPS x (8.5 + 2g) x (4.4 / Y) = $47.28 x (8.5 + 2 x 0.0) x (4.4 / 4.5) = $392.95 (EPS CAGR -20.8% floored at 0%; the formula returns a negative value below -4.25% growth). Current price $389.10; price is 1.0% below the model value.
DCF Value
5/5FCF/share = $53.847, stage 1 growth = 9.1% for 5 years, terminal growth = 3%, discount rate = 10%. Stage 1 PV = $262.70, PV of terminal value = $760.43, DCF value = $1,023.12. Current price $389.10; price is 62.0% below the model value.
Margin of Safety
4/5Graham value $392.95 (price is 1.0% below the model value); DCF value $1,023.12 (price is 62.0% below the model value).
Price-to-Book
5/5P/B of 0.98; the framework scores below 1.0 as 5.
Business quality
Moat Evidence
Not scoredA moat (a brand, a network, switching costs, patents, scale, a licence) is not a number in the filings, so Valerius doesn’t score it. Below are the figures and the words moat analysis starts from, from the company’s own 10-K filings. The conclusion is yours.
Return on capital, each year
Not available: the 10-K financial data has no standard figures for operating income, total assets and current liabilities in the same years, as is common for banks, insurers and REITs.
Gross margin, each year
Not reported: the filings don’t state a gross profit or cost of revenue figure, as is common for oil and gas companies, banks and insurers.
Competition, in the company’s own words · 10-K filed Feb 26, 2026
The global reinsurance and insurance markets are highly competitive and mature. Reinsurance and insurance companies differentiate themselves based on financial strength, range of products, brand recognition, duration of the relationship with the cedents, agent and broker relationships, distribution channels, claims management and customer service. Competition for clients might be based on pricing, capacity, coverage terms, conditions or other factors. We compete in global and local markets with U.S., Bermuda, European, and other international reinsurers and insurers. Reinsurance competitors might include investment companies, mutual companies, insurance companies, alternative risk providers (such as captives, catastrophe bonds and pools) and others, as alternative products are introduced into the capital markets to compete with traditional reinsurance companies. In addition, we also compete with new companies and existing companies that move into the insurance industry. Competitors sell through various distribution channels and business models, across a broad array of product lines and with a high level of variation regarding geographic, marketing and customer segmentation. Human Capital Management. Our colleagues worldwide are essential to our success, and we strive to attract and retain the highest caliber of talent to meet our business needs as well as the needs of our clients and customers.
The opening of the company’s “Competition” section in its 10-K, quoted word for word, not summarized or edited. It is the company’s own description, not Valerius’s view, and may include the company’s expectations. Open the filing.
Return on capital = operating income / (total assets − current liabilities), the ROIC row’s definition; 15% is the framework’s return threshold. Gross margin = gross profit / revenue. Both from each year’s 10-K via SEC EDGAR. Moat analysis commonly looks at whether returns and margins held up over many years. These figures don’t say whether the company has an advantage, what it is, or whether it will last.
Capital Allocation
3/5Capital allocation, 2022-2025: dividends or buybacks paid in every year (pass); $2.27B paid out against $16.27B of free cash flow (pass); total debt $3.08B to $3.59B, up 16.4% (fail: up more than 10%); shares outstanding 0.04B to 0.04B, up 4.1% (fail: up more than 2%). 2 of 4 tests passed; the framework scores that as 3.
Filings
Company notices to the SEC
Not scoredThree kinds of event the company reported to the SEC in the last 5 years, from its filings on SEC EDGAR.
Loading...
These are events the company reported to the SEC. An auditor change or a late filing can have many causes; each date links to the filing, where the company explains it. Valerius does not score these.
How the Graham and DCF values were calculated
Graham Formula:
IV = EPS x (8.5 + 2g) x (4.4 / Y)
EPS = $47.28, g = 0.0%, Y = 4.5
g floored at 0.0% (3-year EPS CAGR was -20.8%; below -4.25% the formula returns a negative value)
IV = $392.95
Current price $389.10 vs Graham value $392.95 — price is 1.0% below the model value.
DCF:
FCF/share = $53.847
Stage 1 growth = 9.1% for 5 years | terminal growth = 3.0% | discount rate = 10.0%
Y1: $58.747 → PV $53.406
Y2: $64.093 → PV $52.969
Y3: $69.925 → PV $52.536
Y4: $76.288 → PV $52.106
Y5: $83.230 → PV $51.680
Stage 1 PV sum = $262.70
Terminal value at end of Y5 = $1,224.68
PV of terminal value = $760.43
DCF value = $1,023.12
Current price $389.10 vs DCF value $1,023.12 — price is 62.0% below the model value.Data from yfinance summary figures and financial statements, and from the company’s 10-K filings via SEC EDGAR; computed at a price of $389.10. Every score is calculated from the figures by the framework’s fixed rules, and the explanation beside it is generated from the same figures: Graham value, DCF value, margin of safety, ROIC, profit margins, debt-to-equity, price-to-book, EPS trend, ROE trend, free cash flow, retained earnings and capital allocation. No AI is involved in this scorecard. The moat is shown as evidence, without a score. Read each score with the figures beside it. A check that cannot be scored from the available data is shown as not scored and left out of the composite score. Intrinsic value calculations are model outputs based on stated assumptions, not predictions.
Recent headlines · third-party publishers · not investment advice
In the news
- Loading headlines...
The 8 newest headlines whose title names the company, shown automatically and never chosen by Valerius. From third-party publishers via Yahoo Finance, linked to the source. Valerius doesn't write or endorse them. Not investment advice.